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Abstract: This study aimed to compare macro- and microstructural neurodegenerative changes remote
from a cervical spinal cord injury in traumatic spinal cord injury (tSCI) and degenerative cervical myelopa-
thy (DCM) patients using quantitative MRI. Twenty-nine tSCI patients, 20 mild/moderate DCM patients
and 22 healthy controls underwent a high-resolution MRI protocol at the cervical cord (C2/C3). High-
resolution T2*-weighted and diffusion-weighted scans provided data to calculate tissue-specific cross-
sectional areas of the spinal cord and tract-specific diffusion indices of cord white matter, respectively.
Regression analysis determined associations between neurodegeneration and clinical impairment. tSCI
patients showed more impairment in upper limb strength and manual dexterity when compared to DCM
patients. While macrostructural MRI measures revealed a similar extent of remote cord atrophy at
cervical level, microstructural measures (diffusion indices) were able to distinguish more pronounced
tract-specific neurodegeneration in tSCI patients when compared to DCM patients. Tract-specific neu-
rodegeneration was associated to upper limb impairment. Despite clinical differences between severely
impaired tSCI compared to mildly affected DCM patient, extensive cord atrophy is present remotely
from the focal spinal cord injury. Diffusion indices revealed greater tract-specific alterations in tSCI
patients. Therefore, diffusion indices are more sensitive than macrostructural MRI measures as these are
able to distinguish between traumatic and non-traumatic spinal cord injury. Neuroimaging biomarkers
of cervical cord integrity hold potential as predictors of recovery and might be suitable biomarkers for
interventional trials both in traumatic and non-traumatic SCI.
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Glossary 
SCI = Spinal Cord Injury; DCM = Degenerative Cervical Myelopathy; AIS = American Spinal 
Injury Association Impairment Scale; DTI = Diffusion Tensor Imaging; ISNCSCI = 
International Standards for Neurological Classification of Spinal Cord Injury; AD = Axial 
Diffusivity; FA = Fractional Anisotropy; GM = Grey Matter; WM = White Matter; RD = 
Radial Diffusivity; SCA = Spinal Cord Area; GRASSP = Graded Redefined Assessment of 

























































































































































































































































































This study aimed to compare macro- and microstructural neurodegenerative changes 
remote from a cervical spinal cord injury in traumatic spinal cord injury (tSCI) and 
degenerative cervical myelopathy (DCM) patients using quantitative MRI.  
Twenty-nine tSCI patients, 20 mild/moderate DCM patients and 22 healthy controls 
underwent a high-resolution MRI protocol at the cervical cord (C2/C3). High-resolution 
T2*-weighted and diffusion-weighted scans provided data to calculate tissue-specific 
cross-sectional areas of the spinal cord and tract-specific diffusion indices of cord white 
matter, respectively. Regression analysis determined associations between 
neurodegeneration and clinical impairment. tSCI patients showed more impairment in 
upper limb strength and manual dexterity when compared to DCM patients. While 
macrostructural MRI measures revealed a similar extent of remote cord atrophy at cervical 
level, microstructural measures (diffusion indices) were able to distinguish more 
pronounced tract-specific neurodegeneration in tSCI patients when compared to DCM 
patients. Tract-specific neurodegeneration was associated to upper limb impairment.  
Despite clinical differences between severely impaired tSCI compared to mildly affected 
DCM patient, extensive cord atrophy is present remotely from the focal spinal cord injury. 
Diffusion indices revealed greater tract-specific alterations in tSCI patients. Therefore, 
diffusion indices are more sensitive than macrostructural MRI measures as these are able 
to distinguish between traumatic and non-traumatic spinal cord injury. Neuroimaging 
biomarkers of cervical cord integrity hold potential as predictors of recovery and might be 
suitable biomarkers for interventional trials both in traumatic and non-traumatic SCI. 

























































































































































































































































































Traumatic spinal cord injury (tSCI) and non-traumatic degenerative cervical myelopathy 
(DCM) are conditions, which arise from focal cervical damage.
1,2
 The most obvious 
difference between a traumatic and non-traumatic cervical myelopathy lies in the time 
profile of neural changes (acute onset in tSCI vs. slowly developing symptoms in DCM).
3–6
 
Due to progressive impairment of gait and the increasing risk of falls, DCM patients can 
develop a central cord syndrome, which per definition is a tSCI.
7
 Experimental evidence 
suggests that, tSCI and DCM share several aspects of myelopathy with a combination of 




 and axonal 
damage of long projecting spinal nerve fibre tracts (white matter damage)
13,14
 as well as 
oedema and ischemic changes.
11,15
 Both aetiologies present with varying degrees of upper 
limb impairment 
16–18
 which can be assessed by comprehensive clinical protocols sensitive 
to sensorimotor functions (e.g. GRASSP).
19,20
 Although, such advanced clinical assessment 
allows quantifying the degree of impairment, it cannot disclose the underlying 
pathophysiology which occurs at the microstructural level.  
Quantitative MRI (qMRI) shows potential to detect such specific (micro-) structural 
changes in the spinal cord, both in tSCI
21–24
 and in DCM patients.
25–27
 To compare the 
magnitude of injury-induced neurodegenerative changes in both aetiologies, we applied 
high resolution T2*-weighted MRI and diffusion tensor imaging (DTI) above the injury 
level. We hypothesized that tSCI patients should show a more pronounced pattern of 
neurodegenerative changes compared to DCM patients, in which the disease slowly 
develops over time. 
Material and Methods 
Participants and study design  
Patients with tSCI at cervical level (n=29, AIS A-D, mean age ± SD = 47.4 ± 19.8 years, five 
female) and patients with mild and moderate DCM (n = 20, AIS D, mean age ± SD = 52.0 ± 
14.5 years, six female) were enrolled in this study at the University Hospital Balgrist Zurich 
between July 2010 and July 2015. DCM patients were recruited at >1 year after onset of 
























































































































































































































































































patients underwent decompressive surgery before study enrolment while all DCM patients 
were in pre-operative phase. 
The exclusion criteria for both groups were pregnancy, head or brain lesions associated 
with spinal cord injury, pre-existing neurological and medical disorders leading to 
functional impairments, mental disorder, or contraindications to MRI, and age <18 and > 
70 years.   
The tSCI patients were divided in two subgroups based on the severity of impairment: AIS 
A and B group (i.e. motor complete) including 10 tSCI patients and AIS C and D group (i.e. 
motor incomplete) including 19 tSCI patients to better account for the severity of tSCI. A 
subset of subjects (17 tSCI patients and 20 DCM patients) included in the present study 
have been previously presented showing cord tissue specific changes induced by spinal 
cord injury in tSCI
23
 or cord myelopathy in DCM 
27
. Additionally, twenty-two healthy 
controls (mean age ± SD = 41.1 ± 11.4 years, 8 female) were enrolled to confirm the group 
difference between patients and healthy controls. 
23,27
 
All patients underwent comprehensive clinical protocols to assess neurologic and 
functional impairment. These included the International Standards for Neurological 
Classification of Spinal Cord Injury (ISNCSCI) protocol for motor score, light-touch, and 
pinprick score and completeness of injury; the Graded Redefined Assessment of Strength, 
Sensibility and Prehension (GRASSP) [max. 232 points] as ancillary outcome measures 
dedicated for the assessment of upper limb function
19
 and the Spinal Cord Independence 
Measure (SCIM). Additionally, all DCM patients were assessed using the modified Japanese 
Orthopaedic Association mJOA) scale [max. 18 points]. The outcome measures such as the 
ISNCSCI protocol for the upper extremity motor score (UEMS) (e.g. pyramidal dysfunction), 
light touch, pinprick, SCIM, and the GRASSP protocol were applied in both SCI and DCM 
patients to enable the comparison between these two aetiologies.  
The local ethics committee of Zurich ‘Kantonale Ethikkommission Zürich’ approved the 
study (KEK-ZH-Nr. –2012-0343), and the study protocols were in accordance with the 


























































































































































































































































































Participants were positioned head-first supine and acquisitions were conducted on a 3T 
MRI system (Skyra
Fit
 Siemens Healthcare, Erlangen, Germany). Radio Frequency (RF) 
excitation was performed using the body coil and detection was achieved using a 
combination of 12-channel head-coil, 4-channel neck-coil and 24-channel spine matrix. 
Subjects were stabilized with an MRI-compatible stifneck (Laerdal Medicals, Stavanger, 
Norway) to minimize motion artefact effects. As a result of motion artefacts, 4 patients (3 
tSCI and 1 DCM patients) and one control were excluded from microstructural assessment.  
All participants underwent a protocol consisting of a T2*-weighted 3D multi-echo 
sequence (multiple echo data image combination; MEDIC) and a diffusion-weighted 
imaging (DWI) sequence based on the reduced-field of view (FOV) single-shot spin-echo 
echo planar imaging (EPI) above the injury and stenosis level. Macrostructural cord 
neurodegeneration was assessed by determining cross-sectional area (SCA) of the cervical 
cord, its grey and white matter using T2*-weighted MRI. The T2*-weighted images 
resulted in five high-resolution axial 3D volumes of the cervical cord with a resolution of 
0.25 × 0.25 × 2.50 mm
3
 within 2.8 minutes acquisition time per volume. MRI parameters of 
MEDIC were as follows: FOV = 162 × 192 mm
2
, matrix size = 648 × 768, repetition time (TR) 
= 44 ms, echo time (TE) = 19 ms, flip angle α = 11° and read- out bandwidth = 260 Hz per 
pixel. To quantify microstructural changes of the spinal cord at the identical level, a high-
resolution DWI scan was applied with cardiac-gating (based on finger pulse oximetry) 
resulting in 30 diffusion-weighted images (b = 500 s/mm
2
) and 6 of b0-weighted images. 
The DWI MRI parameters were as follows: slice thickness=5 mm with 10% inter-slice gap, 
10 slices perpendicularly oriented to the spine, 5/8 Partial-Fourier Imaging in phase-
encoding direction, phase oversampling = 50%, and a cardiac trigger delay = 200 ms, 
acquisition matrix = 176 × 40, FOV = 133 × 30 mm
2
, in-plane resolutions=0.8 × 0.8 mm
2
, TE 
= 73 ms, and TR = 350 ms. The triggered DWI data were acquired in blocks of two slices per 
cardiac cycle. The minimal time between successive triggers was 1800 ms. Each DWI 
dataset was acquired with 4 averages resulting in 144 images within a nominal total 
























































































































































































































































































Data processing  
Cross-sectional spinal cord area measurement 
The serial longitudinal registration in SPM 12 (Wellcome Trust Centre for Neuroimaging, 
University College London, UK) was applied to all T2*-weighted images to average the 
images accounting for intra-participant motion. Jim 6.0 software (Xinapse Systems, 
Aldwincle, UK) was used to merge the adjacent partitions resulting in 10 contiguous slices 
(to increase SNR) and to semi-automatically segment the cross-sectional cervical cord area 
using an active-surface model after setting a marker in the centre of the cord in each of 
the 10 contiguous slices.
28
 The grey matter and white matter cross sectional area were 
manually segmented. The mean interobserver and intra-observer reliability for these 
measures were showed to be in the range of previously reported results (less than 7%). 
27,29
 
Diffusion tensor imaging (DTI) measurement  
Processing of DWI data was carried out with a modified version of the Matlab-based ACID 
toolbox within SPM12 optimized for the spinal cord
30
. First, we reduced the in-plane FOV 
to 24 × 24 mm
2
 to include only spinal cord tissue. Next, diffusion weighted images were 
slice-wise linearly registered with 3 degrees of freedom (df) like translation in the 
frequency- and phase-encoding direction, scaling in the phase-encoding direction to 
correct for intra-participant motion and eddy-current artefacts.
31
 A diffusion tensor model 
was fitted to the DWI data by applying a robust tensor fitting algorithm that accounts for 
outlier volumes due to motion and physiologic artefacts
32
 and resulted fractional 
anisotropy (FA), mean, axial, and radial diffusivity DTI index maps (MD, AD, and RD). The 
DTI maps were spatially normalized to a self-constructed mean diffusivity template 
residing in the spinal Montreal Neurological Institute space.
33
 To further refine the 
accuracy of the registration, a manual slice-by-slice registration (in-plane translation and 
scaling) was performed. Finally, all DTI index maps were smoothed with a full width at half-
maximum Gaussian kernel with 0.5 × 0.5 × 5 mm
3
. All images were visually inspected for 

























































































































































































































































































Statistical analysis  
Statistical analysis of macrostructural MRI data, demographics and clinical outcome data 
was performed with Stata 15 (Stata- Corp LP, College Station, TX). The mean age was not 
statistically different between tSCI and DCM patients (Mann-Whitney U test: Z = 1.06, p = 
0.29).  
First, we assessed the morphometric differences in cord area, GM area, and WM area 
between tSCI subgroups and DCM patients by means of analysis of covariance, adjusted 
for age. For assessing microstructural differences between patient’s groups, we used 
voxel-based analysis of the different DTI indexes (FA, AD, RD) in SPM12, adjusted for age. 
All statistical parametric maps were initially thresholded with a cluster-defining threshold 
of p<0.01 (uncorrected) and clusters surpassing a cluster threshold of p<0.05 (family-wise 
error corrected) are reported. Next, we used linear regression analysis to investigate the 
relationship between cord macrostructural and microstructural changes and clinical 
outcome, adjusted for age. The level of significance was set to p<0.05. 
Data availability statement 
Anonymized grouped data, study protocols, and processing pipelines will be shared by 
request from a qualified investigator. 
Results 
Clinical measures 
Of 29 tSCI patients, seven were complete (AIS A) and 22 incomplete (AIS B-D). The average 
upper-extremity light-touch [max. 32], upper-extremity pin-prick [max. 32] and upper-
extremity motor scores [max. 50] were (mean ± SD) 24.86 ± 5.36, 22.72 ± 6.66, and 37.52 ± 
13.21, respectively. The SCIM [max. 100] and total GRASSP [max. 232] were 62.1 ± 31.99 
and 135.48 ± 66.44, respectively (Table 1).  
In DCM patients, the upper-extremity light-touch score (mean ± SD) was 27.70 ± 4.07, 
upper-extremity pin-prick score was 27.30 ± 3.77, and upper-extremity motor score was 
49.70 ± 0.57. The SCIM was 97.85 ± 4.04. The total GRASSP score was 220.74 ± 12.32 
























































































































































































































































































Orthopaedic Association (mJOA) score which identified 10 patients suffering from mild 
(mJOA ≥ 15 [max. 18]), nine from moderate (mJOA = 12–14) and one from severe (mJOA < 
12) DCM.  
Across group comparison, tSCI patients (divided into AIS A&B and AIS C&D) showed worse 
impairments in upper extremity motor score (p<0.001 and p=0.019, respectively) and 
worse GRASSP scores (p<0.001, p<0.001 respectively) when compared to DCM patients 
(Fig. 1). Pin-prick score was lower in tSCI patients only with AIS A&B compared to DCM 
patients (p = 0.008). In contrast, light touch score was not significantly different comparing 
tSCI patients (AIS A&B and AIS C&D) and DCM patients (p = 0.32, p = 0.29, respectively).  
Cross-sectional spinal cord area  
We first confirmed findings from previous reports  that total cross-sectional spinal cord 
area, grey matter and white matter area are decreased in tSCI (p<0.001) and in DCM 
patients  (p<0.001 ) when compared to the healthy controls.
23,27
 
Between patient groups, the magnitude of remote cord atrophy (i.e. SCA) in tSCI patients 
(AIS A&B: 58.9±11.8 mm
2
, AIS C&D: 75.3±16.7 mm
2
) was not significantly different 
compared to DCM patients (DCM: 68.2±10.4 mm
2
) (AIS A&B vs DCM: p = 0.37, AIS C&D vs 
DCM: p = 0.40) (Fig. 2).  
Accordingly, the difference between the magnitude of atrophy in grey matter area (AIS 
A&B: 10.6±2.6 mm
2
, AIS C&D: 12.8±1.8 mm
2
, DCM: 12.4±1.6 mm
2
); (AIS A&B vs DCM: p = 
0.07, AIS C&D vs DCM: p = 0.95, respectively) and in white matter area (AIS A&B: 48.3±10.2 
mm
2
, AIS C&D: 63.3±15.3 mm
2
, DCM: 55,8±9.2 mm
2
, AIS A&B vs DCM: p = 0.57, AIS C&D vs 
DCM: p = 0.22, respectively) were not significantly different when comparing tSCI to DCM 
patients. 
Microstructural neurodegeneration 
We first confirmed by means of voxel-based analysis of the cervical cord DTI data that tSCI 
and DCM patients show microstructural neurodegenerative changes when compared to 
healthy controls.
23,27
 Specifically, we found that tSCI patients had a 16% decrease in FA 
























































































































































































































































































14% decrease in AD (p = 0.001, localization: x = 4.5, y = −20.0, z = 15; Z-score = 4.77; cluster 
extent = 234) in the dorsal columns, lateral spinothalamic, and CST tracts when compared 
to healthy controls. In DCM patients, FA decreased by 18% in the lateral CST and 
spinothalamic tract when compared to healthy controls (p = 0.023, localization: x = 4.1, y = 
−17.0, z = 21; Z-score = 3.43; cluster extent = 105).  
Comparing tSCI with DCM patients, we found that in tSCI patients, AD was lower in the 
dorsal columns (AIS A&B= –14.4%, p=0.005, localization: x= −0.1, y = −21.9, z = 15; Z-score 
= 3.39; cluster extent = 157) and AIS C&D = –12.6%, p<0.001, and in the lateral 
corticospinal tract (AIS C&D = –11.1%, p = 0.041, localization: x =  1.5, y = −22.6, z = 26; Z-
score = 4.33; cluster extent = 467). FA in dorsal column was lower only in severely impaired 
tSCI patients compared to DCM patients (AIS A&B group = –18.1%, p = 0.001, localization: x 
= 0.7, y = −21.9, z = 21; Z-score = 3.84; cluster extent = 201) (Fig. 3). There were no 
significant differences between RD measured in tSCI and DCM patients. 
Relationship between remote neurodegeneration and clinical outcomes 
Across all patients (tSCI and DCM), grey matter atrophy was associated with upper 
extremity motor score (p = 0.016 R
2 
=0 .2, 95% confidence interval [CI]: 0.38 – 3.58) and 
GRASSP score (p = 0.034, R
2 
= 0.12 95% CI: 0.36 –8.61, adjusted for age (Fig. 4). Mean FA 
within corticospinal tracts and dorsal columns was associated with upper extremity motor 
score (p=0.008, R
2
= 0.21, 95% CI. 7.38 79.30) and SCIM score (p = 0.002, R
2 
= 0.27, 95% CI: 
66.57 232.47). However, micro and macrostructural changes in DCM patients were not 
significantly correlated with corresponding clinical impairments.  
Discussion 
This study shows extensive cord pathology above a traumatic and non-traumatic cervical 
spinal cord injury. While macrostructural MRI measures revealed a similar extent of 
remote cord atrophy, microstructural qMRI measures were able to distinguish more 
pronounced tract-specific neurodegeneration in tSCI patients. The discrepancy between 
different clinical presentation and extensive cord pathology in tSCI and DCM patients may 
be suggestive of compensatory mechanisms owing to the slowly progressing disease in 
























































































































































































































































































suggest that measures of cord atrophy are insensitive to reveal disease specific changes 
while advanced qMRI measures are sensitive to the underlying disease process as it can 
detect tract-specific changes.  





 when compared to the healthy controls. Here we also confirmed that 
the spinal cord atrophy above a cervical injury is different in both patient groups when 
compared to the healthy controls. However, the remote cord atrophy above the injury 
level is remarkably similar when tSCI patients are compared to mild DCM patients.  
 At the microstructural level, previous studies showed that neurodegenerative changes in 
remote cord regions are evident in tSCI 
23,35
  and in DCM patients.
25,27,34
 In this study we 
show that albeit similar macrostructural cord changes, the microstructural integrity of the 
cord is more disturbed in tSCI when compared to DCM above the level of injury. In 
particular, measures of AD (indicating axonal degeneration) in the dorsal column and 
lateral corticospinal tract were reduced in tSCI compared to DCM. In addition,  FA 
(indicating axonal count and myelin content 
36
) in dorsal column was significantly reduced 
in severe tSCI  (AIS A-B) compared to DCM. Measures of AD (indicating axonal 
degeneration) in the dorsal column and lateral corticospinal tract and FA (indicating axonal 
count and myelin content 
36
) in dorsal column were significantly reduced comparing SCI to 
DCM. Previous DTI studies in tSCI and DCM have shown increased RD and decreased FA in 
the supralesional cervical cord
23,27
 remote from the injury level, whereas elevated AD 
values were in different direction in SCI and DCM.
20,24
 This means AD remote from the 
level of stenosis in DCM patients is increased 
27
 while it is decreased in tSCI patients. 
Increased AD in DCM patients may partially be due to elevated fibre tract density driven by 
compression and loss of surrounding cord structure
37
 whereas in tSCI, decreased AD may 





Despite the differences in aetiology, the pathophysiology underlying cord atrophy in both 
tSCI and DCM patients may be driven by similar neurodegenerative mechanisms which are 
revealed by DTI measures. Preclinical studies have highlighted that a range of common 
primary injury mechanisms are involved in both tSCI 
4
 and DCM patients 
15
























































































































































































































































































apoptosis of cells, inflammation and vascular changes resulting in cell death at the focal 
injury site.
5,15,39,40
 Secondary injury-induced changes evolve over time and include 
anterograde and retrograde axonal degeneration of spinal pathyways,
5,14,41,42
 
remodulation of neuronal spinal circuits,
43
 dysregulation of growth factors,
39
 shrinkage of 
the neuron soma size 
44
 due to a reduction in muscle activity of the upper extremity, and 
remodelling of microvasculature configuration. 
40
  
Interestingly, remote neurodegenerative changes (i.e. atrophy) within the cervical grey 
matter in both tSCI and DCM group are associated with upper limb motor function and 
strength, sensibility, and prehension of the upper limbs (i.e., GRASSP). Microstructural 
tract-specific changes (FA) above the level of injury were also related to measures of 
functional independence (i.e., SCIM) and upper limb function. These correlations although 
are mostly driven by SCI patients. Our findings are in line with previous reports showing 
that MRI derived measures of cord macro- and microstructure in the cervical cord are 
associated with clinical impairments.
21,23,27
 These clinicopathologic associations suggest 
that remote reorganizational changes, such as remodulation of intraspinal circuits
43
 
contribute to the level of upper limb function in traumatic and non-traumatic SCI. 
Demonstrating a link between microstructure and function by means of DTI and advanced 
clinical measures of upper limb function (e.g. GRASSP) points towards the applicability of 
such advanced qMRI measures over conventional MRI methods in clinical routines. Thus, 
spinal cord DTI can complement conventional MRI, with the potential to enhance current 
diagnosis and, more importantly, predict outcome in tSCI and DCM patients. In particular, 
FA was found to show the strongest correlation with clinical scores (ISNCSCI scores in tSCI, 
mJOA and Nurick scores in DCM), where lower FA values were associated with higher 
impairment. Neuroimaging biomarkers sensitive to sensorimotor functions could therefore 
be used for the prediction of upper limb recovery and stratification for interventional 
trials.  
This study has some limitations. DCM patients were on average 5 years older than tSCI 
patients. Therefore age was considered as a covariate of no interest in all statistical 
analyses. Voxel-based analysis of DTI indexes in the spinal cord are still under 
























































































































































































































































































common space, an automated post-processing pipeline is yet work under progress. To 
increase the reliability of our analysis, we therefore manually corrected the spatial 
normalization to the template. 
Conclusion  
Despite clinical differences in traumatic and non-traumatic SCI patients, cord atrophy 
rostral to the level of the cervical injury is similar. However, measures of cord atrophy 
represent an accumulation of pathophysiological changes, and as such are insensitive to 
reveal disease specific changes. On the contrary, advanced qMRI measures can detect 
tract-specific changes which are clinically eloquent. Thus, DTI of the cervical cord might be 
a suitable biomarker for outcome prediction and to monitor treatment effects in 
interventional trials in both traumatic and non-traumatic SCI.  
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Table 1: Demographic and clinical information of DCM patients 
GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension [max. 232 points], mJOA = modified Japanese Orthopaedic 
Association [max. 18 points]. UEMS = Upper extremity motor score [max. 50 points]. UELT = Upper extremity light-touch [max. 32 points]. 
UEPP = Upper extremity pin- prick [max. 32 points]. SCIM = Spinal Cord Independence Measure [max. 100 points]. *: Multi-segmental 
degeneration of cervical spine 
ID sex Age, y Stenosis level  GRASSP mJOA UEMS UELT UEPP SCIM 
1 Male 39 C3/4* 225 13 50 25 23 100 
2 Female 53 C5/6 230 16 50 32 30 100
3 Male 72 C7/T1* 222 14 50 26 22 100
4 Female 37 C3/4* 218 14 49 30 30 99 
5 Female 58 C5/6* 220 16 49 29 29 100 
6 Male  55 C6/7 187 12 50 23 23 98 
7 Female 47 C5/6* 232 16 50 31 31 100 
8 Male 63 C4/5* 219 12 50 24 24 95
9 Male 74 C6/7* 215 14 50 32 32 88
10 Male 32 C5/6* 232 16 50 20 20 100 
11 Male 66 C5/6 215 9 50 25 26 86 
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Table2: Demographic and clinical information of the traumatic SCI patients 
AIS = American Spinal Injury Association Impairment Scale, GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension 
[max. 232 points], UEMS = Upper extremity motor score [max. 50 points]. UELT = Upper extremity light-touch [max. 32 points]. UEPP = Upper 
extremity pin- prick [max. 32 points]. SCIM = Spinal Cord Independence Measure [max. 100 points], NA = not available. 
ID Sex Age 
year 
AIS gade Neurologic injury level Years since injury  GRASSP UEMS UELT UEPP SCIM
1 Male 29 A C4 1.0 21 14 15 13 22
2 Female  40 A C4 7.0 43 6 26 12 19
3 Male 25 A C7 0.8 125 35 28 27 47 
4 Male 34 A C4 2.6 98 22 21 18 30 
5 Male 66 A C6 23.9 132 38 20 18 62 
6 Male 68 A C7 1.0 NT 50 28 28 NT 
7 Female 39 B C5 25.0 125 30 28 25 28 
8 Male 50 B C7 25.1 188 46 30 26 63
9 Male 53 B C5 1.5 14 11 20 20 0 
10 Female 32 C C6 1.2 92 26 27 24 23 
11 Male 70 C C2 0.7 71 20 20 16 19 





































































































































































































































































13 Male 45 C C4 20.6 80 22 24 15 27 
14 Male 69 D C7 0.2 206 49 26 25 87 
15 Male 60 D C3 0.3 NT 36 20 20 67
16 Female 63 D C6 0.3 172 41 32 29 70 
17 Male 67 D C7 12.6 183 41 31 32 99 
18 Male 56 D C2 5.6 151 38 24 14 40 
19 Male 43 D C2 13.1 225 47 23 23 74 
20 Male 27 D C7 4.7 189 46 30 32 75 
21 Male 33 D C8 3.0 232 50 31 32 89
22 Male 51 D C1 4.3 130 39 20 16 100 
23 Male 48 D C4 1.8 232 50 32 32 100 
24 Male 50 D C3 7.6 136 38 10 10 97 
25 Male 44 D C6 12.2 NT 50 27 28 100 
26 Male 41 D C8 3.3 NT 48 18 17 100 
27 Male 52 D C8 15.1 NT 50 28 28 90
28 Male 43 D C6 4.6 NT 45 26 25 92





























































































































































































































































































Figure 1: Box plots of upper extremity motor score (UEMS) and total GRASSP scores in 
SCI and DCM patients 
(A): UEMS is significantly lower in both SCI groups (AIS A&B and AIS C&D) compared to 
DCM patients. Additionally, UEMS of SCI with AIS A&B shows significant difference 
compared to SCI with AIS C&D. (B) GRASSP in SCI (AIS A&B and C&D groups) shows 
significant difference compared to the DCM patients, and there is a difference between 
the two SCI groups as well. DCM: degenerative cervical myelopathy, UEMS: upper 
extremity motor scores, GRASSP: Graded Redefined Assessment of Strength, Sensation 
and Prehension, AIS: American Spinal Injury Association Impairment Scale. (*: p<0.01, **: 


























































































































































































































































































Figure 2: Box plots of averaged cross-sectional spinal cord, gray matter, and white 
matter area in SCI and DCM patients 
(A&B&C): Smaller spinal cord, gray matter and white matter area is observed in severely 
impaired SCI with AIS A&B grade compared to those in SCI with AIS C&D grade. However, 
there is no significant difference in cord atrophy comparing SCI and DCM groups. HC: 
healthy controls, AIS: American Spinal Injury Association Impairment Scale, DCM: 


























































































































































































































































































Figure 3: Voxel-wise analysis of microstructural changes above the level of injury (C2/C3 
level) overlaid on the averaged FA maps across subjects in traumatic SCI patients 
compared to DCM patients. A: white matter atlas and hyperintensity signal on the T2*-
weighted scan of a tSCI patient;  B & C show decreased axial diffusivity (AD) in both SCI 
groups (AIS A&B p=0.005, AIS C&D, p<0.001) in dorsal columns and corticospinal tract 
compared to DCM patients. (D) shows decreased fractional anisotropy (FA) in SCI group 
with AIS A&B grade compared to DCM patients in dorsal columns (p<0.001). For 


























































































































































































































































































Figure 4: Associations between remote macrostructural and microstructural MRI 
parameters above the level of injury (C2/C3) and clinical impairments in SCI and DCM 
patients. A & B: the correlation between gray matter area and upper extremity motor 
scores (UEMS) (p=0.016, R
2
=0.2); and total GRASSP score (p= 0.034 R2=0.12). C & D: 
correlation between fractional anisotropy (FA) derived from the corticospinal tract and 
dorsal columns and UEMS (p=0.008, R
2
=0.21) and total SCIM scores (p=0.002, R
2
=0.27) 
respectively.  
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